These mutations are potentially caused by MSI, and although not analyzed in detail here, we also observed ARID1A mutations in our own collection of MMR-D-associated clinical CRC cases (22% of cases harbor mutations in the G7 repeat and have additionally wildtype TP53). This evidence concerns the gene ARID1A and colorectal carcinoma.